28,782 Shares in Intuitive Surgical, Inc. $ISRG Purchased by Danica Pension Livsforsikringsaktieselskab

Danica Pension Livsforsikringsaktieselskab acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 28,782 shares of the medical equipment provider’s stock, valued at approximately $13,268,000.

A number of other institutional investors have also recently made changes to their positions in the business. Norges Bank acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $2,856,987,000. J. Stern & Co. LLP boosted its position in Intuitive Surgical by 18,504.6% in the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock valued at $1,204,788,000 after buying an additional 2,115,814 shares during the period. Northwestern Mutual Wealth Management Co. grew its stake in shares of Intuitive Surgical by 1,043.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock worth $760,124,000 after acquiring an additional 1,224,734 shares in the last quarter. Polen Capital Management LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter worth $477,225,000. Finally, Assenagon Asset Management S.A. increased its position in shares of Intuitive Surgical by 106.6% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock worth $868,667,000 after acquiring an additional 791,516 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Recent commentary highlights that Intuitive Surgical’s latest earnings were impressive, with the company continuing to post strong growth and beating expectations, which supports the long-term investment case. Article Title
• Positive Sentiment: Analysts and recent coverage argue the stock may be oversold, with Wall Street estimate revisions moving higher and some writers saying the pullback could create a buying opportunity for growth investors. Article Title
• Positive Sentiment: One valuation-focused piece says ISRG is being priced for slower growth than it is currently delivering, suggesting the stock could be undervalued if the company maintains its current pace. Article Title
• Neutral Sentiment: Multiple articles note that ISRG has become a heavily watched and widely discussed stock, reflecting heightened investor attention rather than a clear new business catalyst. Article Title
• Negative Sentiment: Despite the strong fundamentals, the stock has fallen sharply over the past several weeks, and several reports frame the decline as a correction driven by investor caution around valuation and recent price weakness. Article Title

Insiders Place Their Bets

In other news, Director Amy L. Ladd sold 119 shares of the firm’s stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the sale, the director owned 120 shares of the company’s stock, valued at approximately $55,620. This trade represents a 49.79% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. The trade was a 46.53% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock valued at $3,059,135 in the last ninety days. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Trading Down 0.9%

Shares of ISRG opened at $350.06 on Wednesday. The firm has a market capitalization of $123.98 billion, a price-to-earnings ratio of 40.10, a PEG ratio of 2.72 and a beta of 1.46. The firm’s fifty day simple moving average is $412.30 and its 200-day simple moving average is $464.06. Intuitive Surgical, Inc. has a twelve month low of $342.10 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 17.09%. The company’s revenue was up 18.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.81 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 8.61 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft reduced their price objective on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research note on Tuesday, June 2nd. Mizuho set a $500.00 target price on Intuitive Surgical and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Robert W. Baird reduced their price target on Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. Finally, JPMorgan Chase & Co. decreased their price objective on Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a research note on Friday, July 17th. Twenty-one research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $523.46.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.